Market Tracker

09/30 3:54pm ET

Protalix Biotherapeutics Inc (NYSE MKT LLC:PLX)

2.44
Data as of 3:38pm ET
 +0.06 / +2.52%
Today’s Change
2.35
Today|||52-Week Range
5.30
-37.28%
Year-to-Date

Today’s Trading

Previous close2.38
Today’s open2.40
Day’s range2.38 - 2.44
Volume166,154
Average volume (3 months)395,273
Market cap$222.9M
Dividend yield--
Data as of 3:38pm ET, 09/30/2014

Growth & Valuation

Earnings growth (last year)-130.77%
Earnings growth (this year)--
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)-66.56%
P/E ratioNM
Price/Sales31.21
Price/Book--

Competitors

 Today’s
change
Today’s
% change
VSTMVerastem Inc+0.02+0.23%
BTXBioTime Inc-0.15-4.57%
NSTGNanoString Technolog...-0.22-2.01%
PSTIPluristem Therapeuti...-0.04-1.37%
Data as of 3:52pm ET, 09/30/2014

Financials

Next reporting dateDecember 3, 2014
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$11.5M
Annual profit (last year)-$27.8M
Net profit margin-241.38%

Profile

Sector
Health Services
Industry
Services to the Health Industry
President, Chief Executive Officer &
Director
David Aviezer
Chief Operating Officer
Tzvi Palash
Corporate headquarters
Carmiel, --

Forecasts